Potential of Selexipag in Chronic Thromboembolic Pulmonary Hypertension Medical Therapy

Circ J. 2020 Sep 25;84(10):1691-1692. doi: 10.1253/circj.CJ-20-0879. Epub 2020 Sep 9.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Acetamides
  • Double-Blind Method
  • Humans
  • Hypertension, Pulmonary* / drug therapy
  • Japan
  • Pyrazines

Substances

  • Acetamides
  • Pyrazines
  • selexipag